Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sharlene Gill
In a ‘Real-World’, Clinic-Based Community Setting, Sorafenib Dose of 400 Mg/Day Is as Effective as Standard Dose of 800 Mg/Day in Patients With Advanced Hepatocellular Carcimona, With Better Tolerance and Similar Survival
Canadian Journal of Gastroenterology
Related publications
Real-World Adverse Events With Niraparib 200 Mg/Day Maintenance Therapy in Ovarian Cancer: A Retrospective Study
Future Oncology
Medicine
Cancer Research
Oncology
Low-Dose Hydroxychloroquine Is as Effective as Phlebotomy in Treatment of Patients With Porphyria Cutanea Tarda
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
A Complete Response Induced by 21-Day Sorafenib Therapy in a Patient With Advanced Hepatocellular Carcinoma
Internal Medicine
Internal Medicine
Medicine
Advanced Hepatocellular Carcinoma: Pretreatment Contrast-Enhanced CT Texture Parameters as Predictive Biomarkers of Survival in Patients Treated With Sorafenib
Radiology
Nuclear Medicine
Radiology
Imaging
1-Day Bowel Preparation With Polyethylene Glycol 3350 Is as Effective and Safe as a 3-Day Preparation for Colonoscopy in Children
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
Sorafenib Dose Escalation Is Not Uniformly Associated With Blood Pressure Elevations in Normotensive Patients With Advanced Malignancies
Clinical Pharmacology and Therapeutics
Pharmacology
Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With NSTEMI After a 180-Mg Loading Dose
Platelets
Medicine
Hematology
Pharmacokinetic Properties of Ibuprofen (IBU) From the Fixed‐Dose Combination IBU/Caffeine (400/100 Mg; FDC) in Comparison With 400 Mg IBU as Acid or Lysinate Under Fasted and Fed Conditions—Data From 2 Single‐Center, Single‐Dose, Randomized Crossover Studies in Healthy Volunteers
Clinical Pharmacology in Drug Development
Pharmacology
Pharmaceutical Science
Post-Progression Survival and Progression-Free Survival in Patients With Advanced Hepatocellular Carcinoma Treated by Sorafenib
Hepatology Research
Hepatology
Infectious Diseases
